{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:40:00Z","timestamp":1788316800637,"version":"build-2803163510"},"reference-count":20,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Medicine"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:p>Vascular involvement in Beh\u00e7et\u2019s disease (BD) occurs in up to 50% of patients. The main mechanism of thrombosis is inflammation. Thus, immunosuppressants (IS) are the mainstay of therapy, and adding anticoagulation (AC) is controversial. In daily practice, we observed that patients who received AC in combination with IS experienced less recurrent thrombosis and decided to investigate our BD patients retrospectively. We hypothesized that adding AC to immunosuppressive therapy may lower the risk of recurrent thrombosis. Treatment at the time of first or recurrent thrombotic events was recorded. Events under the only IS and IS + AC treatments were compared. There were 40 patients (33 males). The most common types of first vascular events were deep vein thrombosis (77.5%) followed by pulmonary embolism (PE) (52.5%). One patient did not receive any treatment. Among the 39 patients, 32 received glucocorticoid and at least one of the azathioprine, or cyclophosphamide, anti-TNF, 5 received monotherapy with azathioprine, 1 received monotherapy with corticosteroid, and the remaining 1 received monotherapy with cyclophosphamide. In total, 22 patients (55%) experienced 27 recurrent venous thromboembolism (VTE) events. Two (7.4%) events while only on AC, 2 (7.4%) events while on AC + IS, and 15 (55.5%) events occurred while on only IS. Eight (19.6%) patients were not receiving any treatment during relapses. The recurrence rate was statistically significantly lower in the IS + AC treatment group compared to IS alone. In conclusion, IS are the mainstay of treatment for BD, and adding AC may help to lower the recurrence risk of thrombotic events.<\/jats:p>","DOI":"10.1177\/10815589241232368","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T06:26:06Z","timestamp":1707978366000},"page":"387-391","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":13,"title":["Does anticoagulation in combination with immunosuppressive therapy prevent recurrent thrombosis in Beh\u00e7et\u2019s disease?"],"prefix":"10.1177","volume":"72","author":[{"given":"Serhat","family":"Erol","sequence":"first","affiliation":[{"name":"Chest Diseases Department, Ankara University, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asl\u0131han","family":"G\u00fcr\u00fcn Kaya","sequence":"additional","affiliation":[{"name":"Chest Diseases Department, Ankara University, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Arslan","sequence":"additional","affiliation":[{"name":"Chest Diseases Department, Ankara University, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Hasanzade","sequence":"additional","affiliation":[{"name":"Chest Diseases Department, Ankara University, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Onur","family":"Da\u015ftan","sequence":"additional","affiliation":[{"name":"Chest Diseases Department, Ankara University, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayd\u0131n","family":"\u00c7ileda\u011f","sequence":"additional","affiliation":[{"name":"Chest Diseases Department, Ankara University, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Eri\u015f G\u00fclbay","sequence":"additional","affiliation":[{"name":"Chest Diseases Department, Ankara University, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ak\u0131n","family":"Kaya","sequence":"additional","affiliation":[{"name":"Chest Diseases Department, Ankara University, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zlem","family":"\u00d6zdemir Kumbasar","sequence":"additional","affiliation":[{"name":"Chest Diseases Department, Ankara University, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6khan","family":"\u00c7elik","sequence":"additional","affiliation":[{"name":"Chest Diseases Department, Ankara University, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turan","family":"Ac\u0131can","sequence":"additional","affiliation":[{"name":"Chest Diseases Department, Ankara University, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,2,29]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00880-7"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-022-02637-1"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213225"},{"key":"e_1_3_2_5_2","first-page":"1078","article-title":"Criteria for diagnosis of Beh\u00e7et\u2019s disease","volume":"335","author":"International Study Group for Beh\u00e7et\u2019s Disease","year":"1990","unstructured":"International Study Group for Beh\u00e7et\u2019s Disease. Criteria for diagnosis of Beh\u00e7et\u2019s disease. Lancet 1990; 335:1078\u20131080.","journal-title":"Lancet"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12107"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-007-0685-z"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.34450"},{"issue":"8","key":"e_1_3_2_9_2","first-page":"1491","article-title":"Vascular Beh\u00e7et\u2019s disease: a comparative study from Turkey and France","volume":"40","author":"Alibaz-Oner F","year":"2022","unstructured":"Alibaz-Oner F, Vautier M, Aksoy A,et al. Vascular Beh\u00e7et\u2019s disease: a comparative study from Turkey and France. Clin Exp Rheumatol 2022; 40(8): 1491\u20131496.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000494"},{"issue":"8","key":"e_1_3_2_11_2","first-page":"1584","article-title":"Histopathology of pulmonary thromboembolism in a patient with Beh\u00e7et\u2019s disease","volume":"40","author":"Tsukui D","year":"2022","unstructured":"Tsukui D, Hirohata S, Kikuchi H,et al. Histopathology of pulmonary thromboembolism in a patient with Beh\u00e7et\u2019s disease. Clin Exp Rheumatol 2022; 40(8): 1584\u20131587.","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"e_1_3_2_12_2","first-page":"57","article-title":"Anticoagulation of Behcet\u2019s disease with thrombosis: a series of 28 cases in a tertiary care centre in Saudi Arabia","volume":"5","author":"Albugami M","year":"2017","unstructured":"Albugami M, Al Shaikh A, Alrashed A,et al. Anticoagulation of Behcet\u2019s disease with thrombosis: a series of 28 cases in a tertiary care centre in Saudi Arabia. Am J Intern Med 2017; 5(4): 57\u201360.","journal-title":"Am J Intern Med"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000263"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-018-1991-y"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-019-02237-7"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-010-1455-x"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz405"},{"key":"e_1_3_2_18_2","first-page":"2164329","article-title":"Successful treatment and secondary prevention of venous thrombosis secondary to Beh\u00e7et Disease with rivaroxaban","volume":"2016","author":"Boban A","year":"2016","unstructured":"Boban A, Lambert C, Hermans C. Successful treatment and secondary prevention of venous thrombosis secondary to Beh\u00e7et Disease with rivaroxaban. Case Rep Hematol 2016; 2016: 2164329.","journal-title":"Case Rep Hematol"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102783"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01620-4"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.5152\/akd.2014.5042"}],"container-title":["Journal of Investigative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10815589241232368","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10815589241232368","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10815589241232368","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:40:01Z","timestamp":1777459201000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10815589241232368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,29]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10.1177\/10815589241232368"],"URL":"https:\/\/doi.org\/10.1177\/10815589241232368","relation":{},"ISSN":["1081-5589","1708-8267"],"issn-type":[{"value":"1081-5589","type":"print"},{"value":"1708-8267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,29]]}}}